Condition
Laryngeal Papilloma, Recurrent
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (2)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03707587Phase 2Completed
M7824 in People With Recurrent Respiratory Papillomatosis
NCT05215249Phase 1WithdrawnPrimary
Optiflow vs. Convential Anesthesia During Pediatric Laryngeal Papilloma Removal
NCT02859454Phase 2Completed
Avelumab for People With Recurrent Respiratory Papillomatosis
Showing all 3 trials